Hair Loss Breakthroughs

The Extreme LaserComb is an effective and FDA-cleared way to treat hair loss by stimulating growth in hair follicles. Using the at-home device  for just 10-15 minutes, three times a week will improve the quality of your hair and limit hair loss.

This breakthrough technology has delivered incredible results, stimulating hair growth in over 95% of users, according to clinical trials.

Summary of Clinical Study – Men

A clinical study was conducted at 4 locations in the United States. All participants in the study were male, diagnosed with hereditary hair loss, which is called Androgenetic Alopecia and had light to medium skin tones. Subjects were divided into two groups, Extreme LC and a Control Group. The Control device looked and sounded like the Extreme device but did not include a laser light. The clinical studies adhered to all GCP (Good Clinical Practice) guidelines, were approved by an IRB (Institutional Review Board) and listed on wwww.clinicaltrials.gov.

During the 6 month clinical study, subjects treated their hair once per day, 3 times per week on non-consecutive days. The numbers of thick, normal healthy hairs in the target zone were counted at week 1, week 16 and week 26.

Results at the 26 week visit showed that over 95% of the men saw an increase in hair counts (based on a minimum of 5 new hairs being observed at the follow up visit).

No subject in the study experienced any serious adverse events. In fact, the number and types of adverse events were similar in the Extreme and control groups.

Hair Count Change

In the clinical study, after 16 and 26 weeks of treatment with the Extreme devices versus the Control Device, the following increases in hair count were found (based on hairs/cm2).

 

Extreme Devices

Control Devices

Number of Subjects

21

22

Average Change in Hair Count (16 weeks)

20.4

4.4

Average Change in Hair Count (26 weeks)

20.9

9.4

95% of study participants showed successful new hair growth with an average hair count increase of 20.9 hairs per cm2 at 26 weeks.
Click to view the clinical study.

 

Summary of Clinical Study – Women

A clinical study was conducted at 5 different locations in the United States. All participants in the study were females, diagnosed with hereditary hair loss, which is called Androgenetic Alopecia and with light to medium skin tones. Subjects were divided into two groups. One group used the Extreme LC and the other group used a control device. The control device looked and sounded like the Extreme LC, but did not include a laser light. The Clinical studies adhered to all GCP (Good Clinical Practice) guidelines, were approved by an IRB (Institutional Review Board) and listed on www. Clinicaltrials.gov.

During the 6 month study, subject treated their hair one per day, 3 times per week, on non-consecutive days. The numbers of thick, normal, healthy hairs in the target area were counted at Week 1, Week 16 and Week 26.

Results at 26 weeks showed that over 95% of the women saw some increases in hair counts (based on a minimum of 5 new hairs being observed at the follow up visit).

No subjects in the study experienced any serious adverse events. In fact, the number and types of adverse events were similar in the Extreme LC and control groups.

Hair Count Change

In the clinical study, after 16 and 26 weeks of treatment with the Extreme LC and a Control Device, the following increased in hair count were found (based on hairs/cm²).

 

Extreme Devices

Control Devices

Number of Subjects

43

22

Average Change in Hair Count (16 weeks)

14.8

1.3

Average Change in Hair Count (26 weeks)

20.5

2.7

Results showed that 100% of study participants showed successful new hair growth with an average hair count increase of 20.5 hairs per cm2 at 26 weeks.
Click to view the clinical study.


Comments

  • http://b54.in/2jbo Shea Lohan

    I am hoping I can get some experienced feedback from the professionals who have been there and done it and are currently doing it in the workforce as of today. Or any great advice will be greatly appreciated!